A Phase II, Open-Label, Ascending High-Dose, Add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs).

Trial Profile

A Phase II, Open-Label, Ascending High-Dose, Add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs).

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2016

At a glance

  • Drugs Perampanel (Primary)
  • Indications Generalised seizures; Partial epilepsies
  • Focus Adverse reactions
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 30 Nov 2016 According to an Eisai media release, the company will present results of this study at the 70th American Epilepsy Society (AES) Annual Meeting.
    • 19 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Sep 2009 Actual initiation date changed from Feb 2009 to Mar 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top